Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2012 Jun 1;83(2):720-6.
doi: 10.1016/j.ijrobp.2011.06.2011. Epub 2011 Nov 19.

Local control with reduced-dose radiotherapy for low-risk rhabdomyosarcoma: a report from the Children's Oncology Group D9602 study

John Breneman  1 , Jane Meza, Sarah S Donaldson, R Beverly Raney, Suzanne Wolden, Jeff Michalski, Fran Laurie, David A Rodeberg, William Meyer, David Walterhouse, Douglas S Hawkins
Affiliations
Clinical Trial

Local control with reduced-dose radiotherapy for low-risk rhabdomyosarcoma: a report from the Children's Oncology Group D9602 study

John Breneman et al. Int J Radiat Oncol Biol Phys. .

Abstract

Purpose: To analyze the effect of reduced-dose radiotherapy on local control in children with low-risk rhabdomyosarcoma (RMS) treated in the Children's Oncology Group D9602 study.

Methods and materials: Patients with low-risk RMS were nonrandomly assigned to receive radiotherapy doses dependent on the completeness of surgical resection of the primary tumor (clinical group) and the presence of involved regional lymph nodes. After resection, most patients with microscopic residual and uninvolved nodes received 36 Gy, those with involved nodes received 41.4 to 50.4 Gy, and those with orbital primary tumors received 45 Gy. All patients received vincristine and dactinomycin, with cyclophosphamide added for patient subsets with a higher risk of relapse in Intergroup Rhabdomyosarcoma Study Group III and IV studies.

Results: Three hundred forty-two patients were eligible for analysis; 172 received radiotherapy as part of their treatment. The cumulative incidence of local/regional failure was 15% in patients with microscopic involved margins when cyclophosphamide was not part of the treatment regimen and 0% when cyclophosphamide was included. The cumulative incidence of local/regional failure was 14% in patients with orbital tumors. Protocol-specified omission of radiotherapy in girls with Group IIA vaginal tumors (n = 5) resulted in three failures for this group.

Conclusions: In comparison with Intergroup Rhabdomyosarcoma Study Group III and IV results, reduced-dose radiotherapy does not compromise local control for patients with microscopic tumor after surgical resection or with orbital primary tumors when cyclophosphamide is added to the treatment program. Girls with unresected nonbladder genitourinary tumors require radiotherapy for postsurgical residual tumor for optimal local control to be achieved.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Statement: None of the authors has a conflict of interest

Figures

Figure 1
Figure 1
Eligibility Criteria and stratification for the COG D9602 Low Risk Rhabdomyosarcoma Study
See this image and copyright information in PMC

References

    1. Meza JL, Anderson J, Pappo AS, Meyer WH. Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the Children’s Oncology Group. J Clin Oncol. 2006;24:3844–51. - PubMed
    1. Etcubanas E, Rao BN, Kun LE, et al. The impact of delayed surgery on radiotherapy dose and local control of rhabdomyosarcoma. Archives of Surgery. 1987;122:1451–4. - PubMed
    1. Mandell L, Ghavimi F, Peretz T, LaQuaglia M, Exelby P. Radiocurability of microscopic disease in childhood rhabdomyosarcoma with radiation doses less than 4,000 cGy. J Clin Oncol. 1990;8:1536–42. - PubMed
    1. Crist WM, Anderson JR, Meza JL, et al. Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease. J Clin Oncol. 2001;19:3091–102. - PubMed
    1. Wiener ES, Lawrence W, Hays D, et al. Retroperitoneal node biopsy in paratesticular rhabdomyosarcoma. J PediatrSurg. 1994;29:171–7. - PubMed

Publication types

MeSH terms